<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d141">
    <sentence id="DDI-DrugBank.d141.s0" text="Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle.">
        <entity charOffset="0-22" id="DDI-DrugBank.d141.s0.e0" text="Immunosuppressive Drugs" type="group"/>
        <entity charOffset="25-47" id="DDI-DrugBank.d141.s0.e1" text="Fibric Acid Derivatives" type="group"/>
        <entity charOffset="50-55" id="DDI-DrugBank.d141.s0.e2" text="Niacin" type="drug"/>
        <entity charOffset="58-71" id="DDI-DrugBank.d141.s0.e3" text="Nicotinic Acid" type="drug"/>
        <entity charOffset="74-85" id="DDI-DrugBank.d141.s0.e4" text="Erythromycin" type="drug"/>
        <entity charOffset="88-104" id="DDI-DrugBank.d141.s0.e5" text="Azole Antifungals" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e0" e2="DDI-DrugBank.d141.s0.e1" id="DDI-DrugBank.d141.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e0" e2="DDI-DrugBank.d141.s0.e2" id="DDI-DrugBank.d141.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e0" e2="DDI-DrugBank.d141.s0.e3" id="DDI-DrugBank.d141.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e0" e2="DDI-DrugBank.d141.s0.e4" id="DDI-DrugBank.d141.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e0" e2="DDI-DrugBank.d141.s0.e5" id="DDI-DrugBank.d141.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e1" e2="DDI-DrugBank.d141.s0.e2" id="DDI-DrugBank.d141.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e1" e2="DDI-DrugBank.d141.s0.e3" id="DDI-DrugBank.d141.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e1" e2="DDI-DrugBank.d141.s0.e4" id="DDI-DrugBank.d141.s0.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e1" e2="DDI-DrugBank.d141.s0.e5" id="DDI-DrugBank.d141.s0.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e2" e2="DDI-DrugBank.d141.s0.e3" id="DDI-DrugBank.d141.s0.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e2" e2="DDI-DrugBank.d141.s0.e4" id="DDI-DrugBank.d141.s0.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e2" e2="DDI-DrugBank.d141.s0.e5" id="DDI-DrugBank.d141.s0.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e3" e2="DDI-DrugBank.d141.s0.e4" id="DDI-DrugBank.d141.s0.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e3" e2="DDI-DrugBank.d141.s0.e5" id="DDI-DrugBank.d141.s0.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s0.e4" e2="DDI-DrugBank.d141.s0.e5" id="DDI-DrugBank.d141.s0.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s1" text="ANTACID (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of antacid.">
        <entity charOffset="0-6" id="DDI-DrugBank.d141.s1.e0" text="ANTACID" type="group"/>
        <entity charOffset="9-36" id="DDI-DrugBank.d141.s1.e1" text="Magnesium-Aluminum Hydroxide" type="drug"/>
        <entity charOffset="40-51" id="DDI-DrugBank.d141.s1.e2" text="Cerivastatin" type="drug"/>
        <entity charOffset="117-123" id="DDI-DrugBank.d141.s1.e3" text="antacid" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e0" e2="DDI-DrugBank.d141.s1.e1" id="DDI-DrugBank.d141.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e0" e2="DDI-DrugBank.d141.s1.e2" id="DDI-DrugBank.d141.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e0" e2="DDI-DrugBank.d141.s1.e3" id="DDI-DrugBank.d141.s1.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e1" e2="DDI-DrugBank.d141.s1.e2" id="DDI-DrugBank.d141.s1.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e1" e2="DDI-DrugBank.d141.s1.e3" id="DDI-DrugBank.d141.s1.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s1.e2" e2="DDI-DrugBank.d141.s1.e3" id="DDI-DrugBank.d141.s1.p5"/>
    <negationtags>ANTACID (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by co-administration of antacid. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s2" text="CIMETlDINE: Cerivastatin plasma concentrations were not affected by co-administration of cimetidine.">
        <entity charOffset="0-9" id="DDI-DrugBank.d141.s2.e0" text="CIMETlDINE" type="drug"/>
        <entity charOffset="12-23" id="DDI-DrugBank.d141.s2.e1" text="Cerivastatin" type="drug"/>
        <entity charOffset="89-98" id="DDI-DrugBank.d141.s2.e2" text="cimetidine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s2.e0" e2="DDI-DrugBank.d141.s2.e1" id="DDI-DrugBank.d141.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s2.e0" e2="DDI-DrugBank.d141.s2.e2" id="DDI-DrugBank.d141.s2.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s2.e1" e2="DDI-DrugBank.d141.s2.e2" id="DDI-DrugBank.d141.s2.p2"/>
    <negationtags>CIMETlDINE: Cerivastatin plasma concentrations were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by co-administration of cimetidine. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s3" text="CHOLESTYRAMINE: The influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies.">
        <entity charOffset="0-13" id="DDI-DrugBank.d141.s3.e0" text="CHOLESTYRAMINE" type="drug"/>
        <entity charOffset="65-78" id="DDI-DrugBank.d141.s3.e1" text="cholestyramine" type="drug"/>
        <entity charOffset="107-125" id="DDI-DrugBank.d141.s3.e2" text="cerivastatin sodium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s3.e0" e2="DDI-DrugBank.d141.s3.e1" id="DDI-DrugBank.d141.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s3.e0" e2="DDI-DrugBank.d141.s3.e2" id="DDI-DrugBank.d141.s3.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s3.e1" e2="DDI-DrugBank.d141.s3.e2" id="DDI-DrugBank.d141.s3.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s4" text="In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.">
        <entity charOffset="57-75" id="DDI-DrugBank.d141.s4.e0" text="cerivastatin sodium" type="drug"/>
        <entity charOffset="86-99" id="DDI-DrugBank.d141.s4.e1" text="cholestyramine" type="drug"/>
        <entity charOffset="189-207" id="DDI-DrugBank.d141.s4.e2" text="cerivastatin sodium" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d141.s4.e0" e2="DDI-DrugBank.d141.s4.e1" id="DDI-DrugBank.d141.s4.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s4.e0" e2="DDI-DrugBank.d141.s4.e2" id="DDI-DrugBank.d141.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s4.e1" e2="DDI-DrugBank.d141.s4.e2" id="DDI-DrugBank.d141.s4.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s5" text="However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.">
        <entity charOffset="53-66" id="DDI-DrugBank.d141.s5.e0" text="cholestyramine" type="drug"/>
        <entity charOffset="110-128" id="DDI-DrugBank.d141.s5.e1" text="cerivastatin sodium" type="drug"/>
        <entity charOffset="210-221" id="DDI-DrugBank.d141.s5.e2" text="cerivastatin" type="drug"/>
        <entity charOffset="304-322" id="DDI-DrugBank.d141.s5.e3" text="cerivastatin sodium" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d141.s5.e0" e2="DDI-DrugBank.d141.s5.e1" id="DDI-DrugBank.d141.s5.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s5.e0" e2="DDI-DrugBank.d141.s5.e2" id="DDI-DrugBank.d141.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s5.e0" e2="DDI-DrugBank.d141.s5.e3" id="DDI-DrugBank.d141.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s5.e1" e2="DDI-DrugBank.d141.s5.e2" id="DDI-DrugBank.d141.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s5.e1" e2="DDI-DrugBank.d141.s5.e3" id="DDI-DrugBank.d141.s5.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s5.e2" e2="DDI-DrugBank.d141.s5.e3" id="DDI-DrugBank.d141.s5.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s6" text="Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.">
        <entity charOffset="58-76" id="DDI-DrugBank.d141.s6.e0" text="cerivastatin sodium" type="drug"/>
        <entity charOffset="99-112" id="DDI-DrugBank.d141.s6.e1" text="cholestyramine" type="drug"/>
        <entity charOffset="213-231" id="DDI-DrugBank.d141.s6.e2" text="cerivastatin sodium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s6.e0" e2="DDI-DrugBank.d141.s6.e1" id="DDI-DrugBank.d141.s6.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s6.e0" e2="DDI-DrugBank.d141.s6.e2" id="DDI-DrugBank.d141.s6.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s6.e1" e2="DDI-DrugBank.d141.s6.e2" id="DDI-DrugBank.d141.s6.p2"/>
    <negationtags>Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; result in a significant decrease in the clinical effect of cerivastatin sodium. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s7" text="DIGOXIN: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.">
        <entity charOffset="0-6" id="DDI-DrugBank.d141.s7.e0" text="DIGOXIN" type="drug"/>
        <entity charOffset="16-22" id="DDI-DrugBank.d141.s7.e1" text="digoxin" type="drug"/>
        <entity charOffset="35-41" id="DDI-DrugBank.d141.s7.e2" text="digoxin" type="drug"/>
        <entity charOffset="118-136" id="DDI-DrugBank.d141.s7.e3" text="cerivastatin sodium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e0" e2="DDI-DrugBank.d141.s7.e1" id="DDI-DrugBank.d141.s7.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e0" e2="DDI-DrugBank.d141.s7.e2" id="DDI-DrugBank.d141.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e0" e2="DDI-DrugBank.d141.s7.e3" id="DDI-DrugBank.d141.s7.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e1" e2="DDI-DrugBank.d141.s7.e2" id="DDI-DrugBank.d141.s7.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e1" e2="DDI-DrugBank.d141.s7.e3" id="DDI-DrugBank.d141.s7.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s7.e2" e2="DDI-DrugBank.d141.s7.e3" id="DDI-DrugBank.d141.s7.p5"/>
    <negationtags>DIGOXIN: Plasma digoxin levels and digoxin clearance at steady-state were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by co-administration of 0.2 mg cerivastatin sodium. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s8" text="Cerivastatin plasma concentrations were also not affected by co-administration of digoxin.">
        <entity charOffset="0-11" id="DDI-DrugBank.d141.s8.e0" text="Cerivastatin" type="drug"/>
        <entity charOffset="82-88" id="DDI-DrugBank.d141.s8.e1" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s8.e0" e2="DDI-DrugBank.d141.s8.e1" id="DDI-DrugBank.d141.s8.p0"/>
    <negationtags>Cerivastatin plasma concentrations were also &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by co-administration of digoxin. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s9" text="WARFARIN: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.">
        <entity charOffset="0-7" id="DDI-DrugBank.d141.s9.e0" text="WARFARIN" type="drug"/>
        <entity charOffset="32-39" id="DDI-DrugBank.d141.s9.e1" text="warfarin" type="drug"/>
        <entity charOffset="45-56" id="DDI-DrugBank.d141.s9.e2" text="cerivastatin" type="drug"/>
        <entity charOffset="191-198" id="DDI-DrugBank.d141.s9.e3" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e0" e2="DDI-DrugBank.d141.s9.e1" id="DDI-DrugBank.d141.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e0" e2="DDI-DrugBank.d141.s9.e2" id="DDI-DrugBank.d141.s9.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e0" e2="DDI-DrugBank.d141.s9.e3" id="DDI-DrugBank.d141.s9.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e1" e2="DDI-DrugBank.d141.s9.e2" id="DDI-DrugBank.d141.s9.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e1" e2="DDI-DrugBank.d141.s9.e3" id="DDI-DrugBank.d141.s9.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s9.e2" e2="DDI-DrugBank.d141.s9.e3" id="DDI-DrugBank.d141.s9.p5"/>
    <negationtags>WARFARIN: Co- administration of warfarin and cerivastatin to healthy volunteers did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s10" text="The AUC and Cmax of both the (R) and (S) isomers of warfarin were unaffected by concurrent dosing of 0.3 mg cerivastatin sodium.">
        <entity charOffset="52-59" id="DDI-DrugBank.d141.s10.e0" text="warfarin" type="drug"/>
        <entity charOffset="108-126" id="DDI-DrugBank.d141.s10.e1" text="cerivastatin sodium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s10.e0" e2="DDI-DrugBank.d141.s10.e1" id="DDI-DrugBank.d141.s10.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s11" text="Co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin sodium.">
        <entity charOffset="21-28" id="DDI-DrugBank.d141.s11.e0" text="warfarin" type="drug"/>
        <entity charOffset="34-45" id="DDI-DrugBank.d141.s11.e1" text="cerivastatin" type="drug"/>
        <entity charOffset="85-103" id="DDI-DrugBank.d141.s11.e2" text="cerivastatin sodium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s11.e0" e2="DDI-DrugBank.d141.s11.e1" id="DDI-DrugBank.d141.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s11.e0" e2="DDI-DrugBank.d141.s11.e2" id="DDI-DrugBank.d141.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s11.e1" e2="DDI-DrugBank.d141.s11.e2" id="DDI-DrugBank.d141.s11.p2"/>
    <negationtags>Co-administration of warfarin and cerivastatin did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; alter the pharmacokinetics of cerivastatin sodium. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d141.s12" text="ERYTHROMYCIN: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.">
        <entity charOffset="0-11" id="DDI-DrugBank.d141.s12.e0" text="ERYTHROMYCIN" type="drug"/>
        <entity charOffset="61-72" id="DDI-DrugBank.d141.s12.e1" text="cerivastatin" type="drug"/>
        <entity charOffset="176-187" id="DDI-DrugBank.d141.s12.e2" text="erythromycin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s12.e0" e2="DDI-DrugBank.d141.s12.e1" id="DDI-DrugBank.d141.s12.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s12.e0" e2="DDI-DrugBank.d141.s12.e2" id="DDI-DrugBank.d141.s12.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d141.s12.e1" e2="DDI-DrugBank.d141.s12.e2" id="DDI-DrugBank.d141.s12.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s13" text="OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.">
        <entity charOffset="106-124" id="DDI-DrugBank.d141.s13.e0" text="cerivastatin sodium" type="drug"/>
        <entity charOffset="154-200" id="DDI-DrugBank.d141.s13.e1" text="angiotensin- converting enzyme (ACE) inhibitors" type="group"/>
        <entity charOffset="203-214" id="DDI-DrugBank.d141.s13.e2" text="betablockers" type="group"/>
        <entity charOffset="217-240" id="DDI-DrugBank.d141.s13.e3" text="calcium-channel blockers" type="group"/>
        <entity charOffset="243-251" id="DDI-DrugBank.d141.s13.e4" text="diuretics" type="group"/>
        <entity charOffset="258-293" id="DDI-DrugBank.d141.s13.e5" text="nonsteroidal anti-inflammatory drugs" type="group"/>
        <entity charOffset="296-301" id="DDI-DrugBank.d141.s13.e6" text="NSAIDs" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e1" id="DDI-DrugBank.d141.s13.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e2" id="DDI-DrugBank.d141.s13.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e3" id="DDI-DrugBank.d141.s13.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e4" id="DDI-DrugBank.d141.s13.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e5" id="DDI-DrugBank.d141.s13.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e2" id="DDI-DrugBank.d141.s13.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e3" id="DDI-DrugBank.d141.s13.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e4" id="DDI-DrugBank.d141.s13.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e5" id="DDI-DrugBank.d141.s13.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e3" id="DDI-DrugBank.d141.s13.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e4" id="DDI-DrugBank.d141.s13.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e5" id="DDI-DrugBank.d141.s13.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p14"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e4" id="DDI-DrugBank.d141.s13.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e5" id="DDI-DrugBank.d141.s13.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e4" e2="DDI-DrugBank.d141.s13.e5" id="DDI-DrugBank.d141.s13.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e4" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d141.s13.e5" e2="DDI-DrugBank.d141.s13.e6" id="DDI-DrugBank.d141.s13.p20"/>
    <negationtags>OTHER CONCOMITANT THERAPY: Although specific interaction studies were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions. &lt;/scope&gt;</negationtags></sentence>
</document>